Bio-Rad Laboratories ddPCR Microsatellite Instability (MSI) Assay

Friday, 19 July, 2019 | Supplied by: Bio-Rad Laboratories Pty Ltd


Bio-Rad’s ddPCR Microsatellite Instability (MSI) Assay can be completed in one day on a ddPCR-based platform to quantify the level of MSI present in colorectal tumours.

Using either a blood or FFPE sample, the RUO assay quantitatively identifies mutations in five loci that lead to identification of MSI status. Colorectal tumours that test positive for MSI-high are candidates for treatment with immune-checkpoint inhibitors.

Simple and sensitive, the assay provides a standardised output that does not require a pathologist’s interpretation. The test can use patient blood samples in the absence of tumour tissue and does not require matched normal tissue or normal blood samples.

Online: www.bio-rad.com
Phone: 02 9914 2800
Related Products

Beckman Coulter Life Sciences Basophil Activation Test (BAT) for food allergy research

Beckman Coulter Life Sciences introduces its next-generation Basophil Activation Test (BAT) to...

TopoGEN Topoisomerase Assay Kits

TopoGEN provides innovative reagents and kits for topoisomerase research and mechanism-based drug...

Alamar Biosciences NULISAseq Mouse Panel 120 for protein biomarker analysis

The multiplex panel encompasses a wide selection of proteins essential for studying key...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd